This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies. Find out more about how we use cookies and how to manage them by viewing our Privacy Policy.
sTMS miniTM by eNeura®— Safe, clinically proven migraine treatment with none of the side effects associated with medications
My gain
Get back what migraine’s been taking away from you.
Missing out on time with friends and family?
Having trouble focusing at work?
Feeling bleary from medication side effects…even when you don’t have a headache?
eNeura helps you stay in control of your days with personal support. Throughout your migraine treatment with the sTMS mini, advice and assistance are available at no cost to you.
Thousands of patients have made a difference in their lives by using the eNeura migraine relief device. eNeura can help you get back what migraine has taken away.
I have fewer headaches per week, the intensity stays reduced for longer periods of time, and I have reduced my rescue meds by half. — 59-year-old female
Thousands of patients have made a difference in their lives by using the eNeura migraine relief device. eNeura can help you get back what migraine has taken away.
I am just ecstatic about the results here. This is truly life-changing for me. — 53-year-old female
Thousands of patients have made a difference in their lives by using the eNeura migraine relief device. eNeura can help you get back what migraine has taken away.
My use of [acute] medication has decreased from 3 or 4 times a week to once or sometimes twice weekly. — 70-year-old female
Indication: The sTMS mini™ by eNeura® is indicated for the acute and prophylactic treatment of migraine headache.
Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754-762.
Lipton RB, Bigal ME, Diamond M. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349.
Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache. 1999;39(suppl 2):S20-S26.
Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005;118(suppl 1):3S-10S.
Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N Eng J Med. 2002;346(4):257-270.
Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15(suppl 1):15S-22S.
Hazard E, Munakata J, Bigal ME, Rupnow MF, Lipton RB. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health. 2009;12(1):55-64.
All-Party Parliamentary Group on Primary Headache Disorders. Headache Disorders – not respected, not resourced. London, UK: House of Commons; 2010.